PMI Picard Medical, Inc.
Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 2030617 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY11.6%
TTM net income YoY37.3%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin26.2%
Operating margin-267.2%
Net margin-371.2%
FCF margin—
EBITDA margin-264.0%
Returns
ROE-425.6%
ROA-175.2%
ROIC (approx.)-350.7%
Asset turnover0.47x
Leverage & solvency
Liabilities / assets85.3%
Debt / equity0.00x
Current ratio0.99x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.58x
Accruals ratio-73.2%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $4.94M | $4.39M |
| Cost of revenue | $5.14M | $4.50M |
| Gross profit | -$204,000 | -$112,000 |
| R&D expense | $3.05M | $3.38M |
| SG&A expense | $10.00M | $10.22M |
| Operating income | -$13.26M | -$13.71M |
| Pretax income | -$26.97M | -$21.07M |
| Income tax | $35,000 | -$15,000 |
| Net income | -$27.00M | -$21.05M |
| EBITDA | -$13.09M | -$13.49M |
| EPS (basic) | -0.75 | -2.99 |
| EPS (diluted) | — | — |
| Balance sheet | ||
| Cash & equivalents | $7.45M | $96,000 |
| Receivables | — | $513,000 |
| Inventory | $7.30M | $8.12M |
| Current assets | $20.73M | $9.79M |
| PP&E, net | $183,000 | $227,000 |
| Goodwill | $615,000 | $615,000 |
| Intangibles | $509,000 | $596,000 |
| Total assets | $22.55M | $12.11M |
| Current liabilities | $18.70M | $35.33M |
| Total liabilities | $18.76M | $35.84M |
| Shareholders' equity | $3.79M | -$44.00M |
| Shares outstanding | 1.47M | 7.94M |
| Cash flow statement | ||
| Operating cash flow | -$15.67M | -$11.87M |
| Investing cash flow | — | $0 |
| Financing cash flow | $27.08M | $11.74M |
| Depreciation & amortization | $163,000 | $226,000 |
| Stock-based compensation | $754,000 | $886,000 |
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.